NEW YORK, Aug. 07, 2017 -- Dr. Anthony Stein, Hematologist/Oncologist, Director of the Leukemia Program, Co-Director of the Gehr Family Center for Leukemia Research, and Clinical Professor of Hematology & Hematopoietic Transplantation at City of Hope in Duarte, is being recognized as one of “America’s Best Doctors”. He will be sharing his knowledge and expertise in Hematology, Oncology, and Medical Oncology.
Dr. Stein has been active in the healthcare industry for the past 38 years. He obtained his M.D. from the University of Cape Town Medical School in Cape Town, South Africa, in 1978 and is board certified in Internal Medicine, Oncology, and Hematology. He completed his internship at the Groote Schuur Hospital (1979), residency at Montefiore Hospital (1985), and fellowship at City of Hope (1988). His interest in Adult Leukemia, as well as his background of clinical training in the field of Oncology during the ‘80s, led him to his current work.
Dr. Stein’s day-to-day responsibilities at City of Hope include leadership and oversight within the hospital’s Leukemia Department, research, and patient care. City of Hope is a leading research and treatment center for cancer, diabetes, and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation.
Dr. Stein attributes his success throughout the course of his career to his more than 30 years of experience in Clinical Research, as well as his various medical publications. He is honored to be Co-Chair of the Leukemia Program at City of Hope, to have his certification in Internal Medicine and Hematology, and to have written a number of peer-reviewed publications regarding his research on Leukemia drugs and treatments. Of all his accomplishments, Dr. Stein is most proud of the work he does to improve the outcome of treatment for his patients. His long-term professional goals include continued growth and further research that will lead to the discovery of new treatments for patients diagnosed with Adult Leukemia.
Dr. Stein is a member of ASH, ASCO, and ASBMT. Charitable organizations he works with include the Leukemia Society.
In his free time, Dr. Stein enjoys playing soccer.
About the American Health Council:
The American Health Council is the nation’s only organization with a constituency representative of all sectors of the healthcare industry. From the coasts to the heartland, the American Health Council has drawn Affiliates from major metropolitan hubs and small communities. These Affiliates span generations and have reached different stages of their careers — from recent graduates to retirees. More information about the American Health Council and its mission can be found at: http://americanhealthcouncil.org
Additionally, the American Health Council strives to provide recognition and support for those individuals and institutions making the difference in patients’ lives day in and day out. Throughout 2017, the AHC is honoring “America’s Best Doctors and Nurses,” as well as the nation’s best medical universities and hospitals. The American Health Council’s “Best in Medicine” and “Best in Nursing” awards programs honor the individuals and institutions that have contributed significantly to medicine and nursing, as well as the training and education of physicians and nurses. The most current selections for these honors may be viewed here: http://bestinmedicine.org and http://bestinnursing.org.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 



